Atlas Venture Associates XII, L.P.'s Net Worth
$65.5 Million
Who is Atlas Venture Associates XII, L.P.?
Atlas Venture Associates XII, L.P. has an estimated net worth of $65.5 Million. This is based on reported shares across multiple companies, which include Vigil Neuroscience, Inc., Aerovate Therapeutics, Inc., and Gemini Therapeutics, Inc. /DE.
SEC CIK
Atlas Venture Associates XII, L.P.'s CIK is 0001845875
Past Insider Trading and Trends
2022 was Atlas Venture Associates XII, L.P.'s most active year for acquiring shares with 3 total transactions. Atlas Venture Associates XII, L.P.'s most active month to acquire stocks was the month of December. 2022 was Atlas Venture Associates XII, L.P.'s most active year for disposing of shares, totalling 2 transactions. Atlas Venture Associates XII, L.P.'s most active month to dispose stocks was the month of December. 2021 saw Atlas Venture Associates XII, L.P. paying a total of $7,499,996.00 for 3,103,879 shares, this is the most they've acquired in one year. In 2021 Atlas Venture Associates XII, L.P. cashed out on 7,976,754 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vigil Neuroscience, Inc. (VIGL) Snapshot price: $2.88
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +304.67% | 4.39M |
$14.00 |
—
| 5.84M |
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gemini Therapeutics, Inc. /DE (IRON) Snapshot price: $65.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aerovate Therapeutics, Inc. (AVTE) Snapshot price: $20.52
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.1M |
$14.00 |
—
| 3.1M |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||